BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37670900)

  • 1. Muscle ultrasound in patients with late-onset Pompe disease identified by newborn screening.
    Jackson DG; Case LE; Huggins E; Holland M; Blount J; Webb LH; Kishnani PS
    Mol Genet Metab Rep; 2023 Sep; 36():100989. PubMed ID: 37670900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newborn screening for Pompe disease in Italy: Long-term results and future challenges.
    Gragnaniello V; Pijnappel PWWM; Burlina AP; In 't Groen SLM; Gueraldi D; Cazzorla C; Maines E; Polo G; Salviati L; Di Salvo G; Burlina AB
    Mol Genet Metab Rep; 2022 Dec; 33():100929. PubMed ID: 36310651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13T>G "late-onset" GAA variant.
    Rairikar MV; Case LE; Bailey LA; Kazi ZB; Desai AK; Berrier KL; Coats J; Gandy R; Quinones R; Kishnani PS
    Mol Genet Metab; 2017 Nov; 122(3):99-107. PubMed ID: 28951071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative whole-body magnetic resonance imaging in children with Pompe disease: Clinical tools to evaluate severity of muscle disease.
    Fernandes SA; Khan AA; Boggs T; Bowling M; Austin S; Stefanescu M; Case L; Kishnani PS
    JIMD Rep; 2021 Jan; 57(1):94-101. PubMed ID: 33473345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline Urinary Glucose Tetrasaccharide Concentrations in Patients with Infantile- and Late-Onset Pompe Disease Identified by Newborn Screening.
    Chien YH; Goldstein JL; Hwu WL; Smith PB; Lee NC; Chiang SC; Tolun AA; Zhang H; Vaisnins AE; Millington DS; Kishnani PS; Young SP
    JIMD Rep; 2015; 19():67-73. PubMed ID: 25681082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tongue weakness and atrophy differentiates late-onset Pompe disease from other forms of acquired/hereditary myopathy.
    Jones HN; Hobson-Webb LD; Kuchibhatla M; Crisp KD; Whyte-Rayson A; Batten MT; Zwelling PJ; Kishnani PS
    Mol Genet Metab; 2021 Jul; 133(3):261-268. PubMed ID: 34053870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health care practitioners' experience-based opinions on providing care after a positive newborn screen for Pompe disease.
    Davids L; Sun Y; Moore RH; Lisi E; Wittenauer A; Wilcox WR; Ali N
    Mol Genet Metab; 2021; 134(1-2):20-28. PubMed ID: 34602357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early clinical phenotype of late onset Pompe disease: Lessons learned from newborn screening.
    Huggins E; Holland M; Case LE; Blount J; Landstrom AP; Jones HN; Kishnani PS
    Mol Genet Metab; 2022 Mar; 135(3):179-185. PubMed ID: 35123877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of short- and long-term inspiratory muscle training in late-onset Pompe disease (LOPD): a pilot study.
    Wenninger S; Greckl E; Babačić H; Stahl K; Schoser B
    J Neurol; 2019 Jan; 266(1):133-147. PubMed ID: 30430231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-body magnetic resonance imaging in late-onset Pompe disease: Clinical utility and correlation with functional measures.
    Khan AA; Boggs T; Bowling M; Austin S; Stefanescu M; Case L; Kishnani PS
    J Inherit Metab Dis; 2020 May; 43(3):549-557. PubMed ID: 31710733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasonography of abdominal muscles: Differential diagnosis of late-onset Pompe disease and myotonic dystrophy type 1.
    Hsieh PC; Chang CW; Ro LS; Huang CC; Chi JE; Kuo HC
    Front Neurol; 2022; 13():944464. PubMed ID: 36147041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of Later-Onset Pompe Disease Identified Through Newborn Screening.
    Lee NC; Chang KL; In 't Groen SLM; de Faria DOS; Huang HJ; Pijnappel WWMP; Hwu WL; Chien YH
    J Pediatr; 2022 May; 244():139-147.e2. PubMed ID: 34995642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sonographic evaluations of the skeletal muscles in patients with Pompe disease.
    Chiu YH; Liao CL; Chien YH; Wu CH; Özçakar L
    Eur J Paediatr Neurol; 2023 Jan; 42():22-27. PubMed ID: 36508847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-onset Pompe disease (LOPD) in Belgium: clinical characteristics and outcome measures.
    Vanherpe P; Fieuws S; D'Hondt A; Bleyenheuft C; Demaerel P; De Bleecker J; Van den Bergh P; Baets J; Remiche G; Verhoeven K; Delstanche S; Toussaint M; Buyse B; Van Damme P; Depuydt CE; Claeys KG
    Orphanet J Rare Dis; 2020 Apr; 15(1):83. PubMed ID: 32248831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Qualitative Study: Mothers' Experiences of Their Child's Late-Onset Pompe Disease Diagnosis Following Newborn Screening.
    Crossen K; Berry L; Myers MF; Leslie N; Goueli C
    Int J Neonatal Screen; 2022 Jul; 8(3):. PubMed ID: 35892473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential patient screening for late-onset Pompe disease in suspected sleep apnea: a rationale and study design for a Prospective Multicenter Observational Cohort Study in Japan (PSSAP-J Study).
    Yamauchi M; Nakayama H; Shiota S; Ohshima Y; Terada J; Nishijima T; Kosuga M; Kitamura T; Tachibana N; Oguri T; Shirahama R; Aoki Y; Ishigaki K; Sugie K; Yagi T; Muraki H; Fujita Y; Takatani T; Muro S
    Sleep Breath; 2021 Jun; 25(2):695-704. PubMed ID: 32808237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are there common walking gait characteristics in patients diagnosed with late-onset Pompe disease?
    Starbuck C; Reay J; Silk E; Roberts M; Hendriksz C; Jones R
    Hum Mov Sci; 2021 Jun; 77():102777. PubMed ID: 33730657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk screening of late-onset Pompe disease: A different early portrait in China.
    Jiao K; Dong J; Luo S; Yu L; Ke Q; Wang Z; Luan X; Zhang X; Guo J; Chen Y; Li X; Tan S; Qian F; Jiang J; Yu X; Yue D; Liu C; Luo L; Li J; Qu Y; Chen L; Tu J; Sun C; Yan C; Song J; Xi J; Lin J; Lu J; Zhao C; Zhu W; Fang Q
    Front Neurol; 2022; 13():965207. PubMed ID: 36237614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early-onset of symptoms and clinical course of Pompe disease associated with the c.-32-13 T > G variant.
    Herbert M; Case LE; Rairikar M; Cope H; Bailey L; Austin SL; Kishnani PS
    Mol Genet Metab; 2019 Feb; 126(2):106-116. PubMed ID: 30655185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective screening of late-onset Pompe disease (LOPD) in patients with non-diagnostic muscle biopsies.
    Meznaric M; Fumic K; Leonardis L
    J Clin Pathol; 2019 Jul; 72(7):468-472. PubMed ID: 30878973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.